Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,501 | 597 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,620 | 88 | $0 (2024) |
| Novo Nordisk Inc | $1,104 | 35 | $0 (2024) |
| PFIZER INC. | $924.21 | 62 | $0 (2024) |
| Amgen Inc. | $826.60 | 35 | $0 (2024) |
| Lilly USA, LLC | $810.26 | 49 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $789.29 | 36 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $492.28 | 26 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $408.69 | 21 | $0 (2024) |
| Lundbeck LLC | $389.67 | 9 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $370.40 | 15 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,650 | 109 | ABBVIE INC. ($385.74) |
| 2023 | $3,060 | 154 | PFIZER INC. ($396.45) |
| 2022 | $3,626 | 182 | Lilly USA, LLC ($402.74) |
| 2021 | $3,164 | 152 | AbbVie Inc. ($568.17) |
All Payment Transactions
597 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $148.67 | General |
| Category: Diabetes Care | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Gastroenterology | ||||||
| 12/11/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $20.80 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/04/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Diabetes Care | ||||||
| 12/02/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Neuroscience | ||||||
| 11/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.30 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $91.58 | General |
| Category: Bone Health | ||||||
| 11/13/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Gastroenterology | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Biological | ||||||
| 11/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: PAIN | ||||||
| 11/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: VACCINES | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Neuroscience | ||||||
| 10/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/14/2024 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,474 | 2,446 | $189,451 | $58,822 |
| 2022 | 26 | 1,395 | 2,390 | $157,930 | $54,994 |
| 2021 | 25 | 1,798 | 2,951 | $146,143 | $67,030 |
| 2020 | 22 | 1,495 | 2,364 | $122,913 | $45,947 |
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 211 | 358 | $73,748 | $22,711 | 30.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 175 | 221 | $30,940 | $10,043 | 32.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 89 | 89 | $22,250 | $9,057 | 40.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $7,920 | $3,395 | 42.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 181 | 273 | $6,825 | $2,293 | 33.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 29 | 29 | $3,074 | $2,086 | 67.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 106 | 231 | $11,319 | $1,769 | 15.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 94 | 111 | $7,992 | $1,444 | 18.1% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 37 | 37 | $3,700 | $1,281 | 34.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 33 | 33 | $1,386 | $925.65 | 66.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 77 | 82 | $2,378 | $618.46 | 26.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 16 | 32 | $1,056 | $519.04 | 49.2% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2023 | 30 | 39 | $1,365 | $371.28 | 27.2% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 15 | 29 | $696.00 | $358.15 | 51.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $504.00 | $336.60 | 66.8% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 19 | 19 | $627.00 | $307.80 | 49.1% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 49 | 53 | $583.00 | $275.03 | 47.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 25 | 28 | $1,232 | $266.56 | 21.6% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 15 | 17 | $1,071 | $265.59 | 24.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 90 | 109 | $1,417 | $238.44 | 16.8% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 58 | 264 | $7,920 | $93.16 | 1.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 22 | 24 | $432.00 | $81.84 | 18.9% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 11 | 92 | $644.00 | $38.09 | 5.9% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 15 | 24 | $144.00 | $28.23 | 19.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 53 | 228 | $228.00 | $18.94 | 8.3% |
About Jill Easley
Jill Easley is a Family healthcare provider based in Madison, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2014. The National Provider Identifier (NPI) number assigned to this provider is 1891100970.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jill Easley has received a total of $12,501 in payments from pharmaceutical and medical device companies, with $2,650 received in 2024. These payments were reported across 597 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($12,501).
As a Medicare-enrolled provider, Easley has provided services to 6,162 Medicare beneficiaries, totaling 10,151 services with total Medicare billing of $226,793. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Madison, MS
- Active Since 06/26/2014
- Last Updated 03/25/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1891100970
Products in Payments
- NURTEC ODT (Drug) $1,037
- VRAYLAR (Drug) $642.76
- FARXIGA (Drug) $559.86
- Wegovy (Drug) $505.58
- MOUNJARO (Drug) $473.14
- UBRELVY (Drug) $465.71
- TRINTELLIX (Drug) $416.61
- XIFAXAN (Drug) $357.95
- EVENITY (Biological) $318.05
- QULIPTA (Drug) $311.94
- Auvelity (Drug) $284.72
- ELIQUIS (Drug) $279.88
- Veozah (Drug) $265.83
- VYEPTI (Biological) $256.22
- Saxenda (Drug) $238.72
- Repatha (Biological) $233.83
- XARELTO (Drug) $232.68
- REXULTI (Drug) $214.22
- BREZTRI (Drug) $207.98
- Aimovig (Biological) $192.37
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Madison
Kelli Cranford, Np, NP
Family — Payments: $7,945
Melissa Jackson, Fnp, FNP
Family — Payments: $7,711
Dean Whitley, Np, NP
Family — Payments: $7,484
Brittany Hart, Fnp-C, FNP-C
Family — Payments: $6,900
Mrs. Chassity Jones, Aprn, Fnp-Bc, APRN, FNP-BC
Family — Payments: $4,960
Susan Furtwengler, Crnp, CRNP
Family — Payments: $4,387